Shao Lee Lin is EVP, Head of R&D and CSO of Horizon Therapeutics Public Ltd Co. Currently has a direct ownership of 109,668 shares of HZNP, which is worth approximately $0. The most recent transaction as insider was on Jan 21, 2020, when has been sold 2,716 shares (Ordinary Shares) at a price of $38.25 per share, resulting in proceeds of $103,887. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 110K
0% 3M change
0% 12M change
Total Value Held $0

Shao-Lee Lin Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 21 2020
SELL
Payment of exercise price or tax liability
$103,887 $38.25 p/Share
2,716 Reduced 2.42%
109,668 Ordinary Shares
Jan 21 2020
BUY
Grant, award, or other acquisition
-
6,129 Added 5.17%
112,384 Ordinary Shares
Jan 05 2020
SELL
Payment of exercise price or tax liability
$1,375,410 $36.1 p/Share
38,100 Reduced 26.39%
106,255 Ordinary Shares
Jan 05 2020
BUY
Grant, award, or other acquisition
-
35,652 Added 19.81%
144,355 Ordinary Shares
Jan 05 2020
BUY
Exercise of conversion of derivative security
-
50,344 Added 31.65%
108,703 Ordinary Shares
Jan 04 2020
SELL
Payment of exercise price or tax liability
$292,879 $36.1 p/Share
8,113 Reduced 12.21%
58,359 Ordinary Shares
Jan 04 2020
BUY
Exercise of conversion of derivative security
-
17,892 Added 21.21%
66,472 Ordinary Shares
Feb 20 2019
SELL
Payment of exercise price or tax liability
$340,224 $21.54 p/Share
15,795 Reduced 24.94%
47,531 Ordinary Shares
Feb 20 2019
BUY
Grant, award, or other acquisition
-
35,652 Added 36.02%
63,326 Ordinary Shares
Jan 05 2019
SELL
Payment of exercise price or tax liability
$292,331 $20.39 p/Share
14,337 Reduced 34.13%
27,674 Ordinary Shares
Jan 05 2019
BUY
Exercise of conversion of derivative security
-
32,362 Added 43.51%
42,011 Ordinary Shares
Jan 04 2019
SELL
Payment of exercise price or tax liability
$168,054 $20.39 p/Share
8,242 Reduced 46.07%
9,649 Ordinary Shares
Jan 04 2019
BUY
Exercise of conversion of derivative security
-
17,891 Added 50.0%
17,891 Ordinary Shares

Also insider at

SRZN
Surrozen, Inc. Healthcare
THRD
Third Harmonic Bio, Inc. Healthcare
SLRN
ACELYRIN, Inc.
SL

Shao Lee Lin

EVP, Head of R&D and CSO
Dublin, L2

Track Institutional and Insider Activities on HZNP

Follow Horizon Therapeutics Public Ltd Co and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HZNP shares.

Notify only if

Insider Trading

Get notified when an Horizon Therapeutics Public LTD CO insider buys or sells HZNP shares.

Notify only if

News

Receive news related to Horizon Therapeutics Public Ltd Co

Track Activities on HZNP